Montelukast Lhc 10 mg/200 mg/350 mg FC Tablets,
PDF Leaflet Revision Date: 31 January 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylaxis and chronic treatment of atopic asthma in adults and children 15 years and older.
Dosage (summary)
One 10 mg tablet daily in the evening.
Onset of Action / Duration
Onset: 1 day, Duration: Not specified
Special Populations
- Hepatic impairment
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Safety in pregnancy and breastfeeding not established; avoid breastfeeding.
Key Drug Interactions
- Phenobarbital
- Gemfibrozil
- Ritonavir
- Phenytoin
- Rifampicin
Contraindications
- Hypersensitivity to montelukast
- Children under 15 years
Common side effects
- Dizziness
- Headache
- Abdominal pain
- Nausea
- Fatigue
Counselling Points
- Take daily as prescribed
- Have rescue medication available
- Report any mood changes
- Avoid aspirin if sensitive
Serious warnings
- Not for acute asthma attacks
- Neuropsychiatric events
- Eosinophilic conditions
Important Disclaimer
The Montelukast Lhc 10 mg/200 mg/350 mg FC Tablets, professional information leaflet below is the property of Lhc Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
